Literature DB >> 22156924

Angiogenesis in synchronous and metachronous colorectal liver metastases: the liver as a permissive soil.

Gesiena E van der Wal1, Annette S H Gouw, Jan A A M Kamps, Henk E Moorlag, Marian L C Bulthuis, Grietje Molema, Koert P de Jong.   

Abstract

OBJECTIVE: Resection of a primary colorectal carcinoma (CRC) can be accompanied by rapid outgrowth of liver metastases, suggesting a role for angiogenesis. The aim of this study is to investigate whether the presence of a primary CRC is associated with changes in angiogenic status and proliferation/apoptotic rate in synchronous liver metastases and/or adjacent liver parenchyma.
METHODS: Gene expression and localization of CD31, HIF-1α, members of the vascular endothelial growth factor (VEGF) and Angiopoietin (Ang) system were studied using qRT-PCR and immunohistochemistry in colorectal liver metastases and nontumorous-adjacent liver parenchyma. Proliferation and apoptotic rate were quantified. Three groups of patients were included: (1) simultaneous resection of synchronous liver metastases and primary tumor (SS-group), (2) resection of synchronous liver metastases 3 to 12 months after resection of the primary tumor [late synchronous (LS-group)], and (3) resection of metachronous metastases >14 months after resection of the primary tumor (M-group).
RESULTS: In all 3 groups a higher expression of the angiogenic factors was encountered in adjacent liver parenchyma as compared to the metastases. VEGFR-2 gene expression was abundant in adjacent liver parenchyma in all 3 groups. VEGF-A and VEGFR-1 were prominent in adjacent parenchyma in the SS-group. The SS-group showed the highest Ang-2/Ang-1 ratio both in the metastases and the adjacent liver. This was accompanied by a high turnover of tumor cells.
CONCLUSION: In the presence of the primary tumor, the liver parenchyma adjacent to the synchronous liver metastases provides an angiogenic prosperous environment for metastatic tumor growth.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22156924     DOI: 10.1097/SLA.0b013e318238346a

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  28 in total

1.  A specific KRAS codon 13 mutation is an independent predictor for colorectal cancer metachronous distant metastases.

Authors:  Qingyang Feng; Li Liang; Li Ren; Jingwen Chen; Ye Wei; Wenju Chang; Dexiang Zhu; Qi Lin; Peng Zheng; Jianmin Xu
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

2.  Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.

Authors:  C Lim; A Doussot; M Osseis; F Esposito; C Salloum; J Calderaro; C Tournigand; D Azoulay
Journal:  Clin Transl Oncol       Date:  2018-03-28       Impact factor: 3.405

3.  Macrophage stimulating protein promotes liver metastases of small cell lung cancer cells by affecting the organ microenvironment.

Authors:  Seidai Sato; Masaki Hanibuchi; Takuya Kuramoto; Nodoka Yamamori; Hisatsugu Goto; Hirohisa Ogawa; Atsushi Mitsuhashi; Trung The Van; Soji Kakiuchi; Shin-ichi Akiyama; Yasuhiko Nishioka; Saburo Sone
Journal:  Clin Exp Metastasis       Date:  2012-09-26       Impact factor: 5.150

4.  Primary Tumor Resection in Patients with Incurable Localized or Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.

Authors:  Constantinos Simillis; Eliana Kalakouti; Thalia Afxentiou; Christos Kontovounisios; Jason J Smith; David Cunningham; Michel Adamina; Paris P Tekkis
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

5.  Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer.

Authors:  Amber L Simpson; Alexandre Doussot; John M Creasy; Lauryn B Adams; Peter J Allen; Ronald P DeMatteo; Mithat Gönen; Nancy E Kemeny; T Peter Kingham; Jinru Shia; William R Jarnagin; Richard K G Do; Michael I D'Angelica
Journal:  Ann Surg Oncol       Date:  2017-05-30       Impact factor: 5.344

Review 6.  VEGF levels and the angiogenic potential of the microenvironment can affect surgical strategy for colorectal liver metastasis.

Authors:  Clarisse Eveno; Marc Pocard
Journal:  Cell Adh Migr       Date:  2012-11-01       Impact factor: 3.405

Review 7.  Primary tumor resection in colorectal cancer with unresectable synchronous metastases: A review.

Authors:  Louis de Mestier; Gilles Manceau; Cindy Neuzillet; Jean Baptiste Bachet; Jean Philippe Spano; Reza Kianmanesh; Jean Christophe Vaillant; Olivier Bouché; Laurent Hannoun; Mehdi Karoui
Journal:  World J Gastrointest Oncol       Date:  2014-06-15

8.  miR-155 overexpression is followed by downregulation of its target gene, NFE2L2, and altered pattern of VEGFA expression in the liver of melanoma B16-bearing mice at the premetastatic stage.

Authors:  Mariya B Aksenenko; Nadezhda V Palkina; Olga N Sergeeva; Ekaterina Yu Sergeeva; Andrey K Kirichenko; Tatiana G Ruksha
Journal:  Int J Exp Pathol       Date:  2020-02-11       Impact factor: 1.925

Review 9.  Management of colorectal cancer presenting with synchronous liver metastases.

Authors:  Ajith K Siriwardena; James M Mason; Saifee Mullamitha; Helen C Hancock; Santhalingam Jegatheeswaran
Journal:  Nat Rev Clin Oncol       Date:  2014-06-03       Impact factor: 66.675

Review 10.  The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review.

Authors:  A A P Slesser; P Georgiou; G Brown; S Mudan; R Goldin; P Tekkis
Journal:  Clin Exp Metastasis       Date:  2012-11-23       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.